Mutant valosin‐containing protein causes a novel type of frontotemporal dementia
暂无分享,去创建一个
K. Fliessbach | S. Mehta | V. Hans | V. Kimonis | B. Evert | D. Thal | R. Schröder | K. Pauls | G. Watts | P. Broich
[1] H. Feldman,et al. Neuronal Intranuclear Inclusions Distinguish Familial FTD-MND Type from Sporadic Cases , 2004, Dementia and Geriatric Cognitive Disorders.
[2] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[3] E. Cochran,et al. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2004 .
[4] H. Feldman,et al. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases , 2003, Acta Neuropathologica.
[5] 和田 千鶴,et al. タウ変異を伴うFrontotemporal dementia and parkinsonism linked to chromosome 17の言語症状を主体とした臨床症状の検討 , 2002 .
[6] K. Fröhlich,et al. AAA-ATPase p97/Cdc48p, a Cytosolic Chaperone Required for Endoplasmic Reticulum-Associated Protein Degradation , 2002, Molecular and Cellular Biology.
[7] M. Hetzer,et al. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly , 2001, Nature Cell Biology.
[8] K. Tanaka,et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration , 2001, Cell Death and Differentiation.
[9] W. Kamphorst,et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.
[10] Chou-Chi H. Li,et al. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation , 2001, Nature Cell Biology.
[11] Andrew Kertesz,et al. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.
[12] D. Pappin,et al. A complex of mammalian Ufd1 and Npl4 links the AAA‐ATPase, p97, to ubiquitin and nuclear transport pathways , 2000, The EMBO journal.
[13] C. Elger,et al. Plectin in the human central nervous system: predominant expression at pia/glia and endothelia/glia interfaces , 1998, Acta Neuropathologica.
[14] Hisao Kondo,et al. Syntaxin 5 Is a Common Component of the NSF- and p97-Mediated Reassembly Pathways of Golgi Cisternae from Mitotic Golgi Fragments In Vitro , 1998, Cell.
[15] D. Longo,et al. Involvement of Valosin-containing Protein, an ATPase Co-purified with IκBα and 26 S Proteasome, in Ubiquitin-Proteasome-mediated Degradation of IκBα* , 1998, The Journal of Biological Chemistry.
[16] G. Jicha,et al. A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.
[17] Hisao Kondo,et al. p47 is a cofactor for p97-mediated membrane fusion , 1997, Nature.
[18] M. Goedert,et al. Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.
[19] A. Delacourte,et al. Tau antigenic changes induced by glutamate in rat primary culture model: A biochemical approach , 1992, Neuroscience Letters.
[20] H. Braak,et al. Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.
[21] P. Timiras,et al. The amount and distribution of pigments in neurons and glia of the cerebral cortex. Autofluorescent and ultrastructural studies. , 1969, Journal of gerontology.
[22] D. Longo,et al. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. , 1998, The Journal of biological chemistry.